Influence of IL-10 polymorphism on the development of coronary artery disease in Pakistan

1. Tregouöt Tregouet DA, Konig RI, Erdmann J, Munteanu A, Braund PS, Hall AS, et al. Genome-wide haplotype association study identifies the SLC22A3- LPAL2-LPA gene cluster as a risk locus for coronary artery disease. Nat Gen. 2009; 4:283-5.10.1038/ng.31419198611Search in Google Scholar

2. Murray CJL, Lopez AD. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Boston, Mass: Harvard School of Public Health. 1996.Search in Google Scholar

3. Pakistan Medical Research Council. National Health Survey of Pakistan 1990-94. Islamabad, Pakistan: Pakistan Medical Research Council, Network Publication Service. 1998.Search in Google Scholar

4. Apostolakis S, Baritaki S, Kochiadakis GE, Igoumenidis NE, Panutsopulos D, Demetrios A. et al. Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease. Thromb Res. 2007; 119:63-71.10.1016/j.thromres.2005.12.01616480760Open DOISearch in Google Scholar

5. Sarecka B , Zak I , Krauze J. Synergistic effects of the polymorphisms in the PAI-1 and IL-6 genes with smoking in determining their associated risk with coronary artery disease. Clin Biochem. 2008; 4:467-73.10.1016/j.clinbiochem.2008.01.02818307986Search in Google Scholar

6. Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol. Rev. 2006; 86:515-81.Search in Google Scholar

7. Heiskanen M, Kahonen M, Hurme M, Lehtimaki T, Mononen N, Juonala M, et al. Polymorphism in the IL-10 promoter region and early markers of atherosclerosis: The Cardiovascular Risk in Young Finns Study. Atherosclerosis. 2010; 208:190-6.10.1016/j.atherosclerosis.2009.06.03219700159Open DOISearch in Google Scholar

8. Thio C. Host genetic factors and antiviral immune responses to HCV. Clin Liver Dis. 2008; 12:713-26.10.1016/j.cld.2008.03.002259729918625436Open DOISearch in Google Scholar

9. Rousset F, Garcia E, Defrance T, P_ronne C, Vezzio N, Hsu DH, et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA.1992; 89:1890-3.10.1073/pnas.89.5.1890485591371884Open DOISearch in Google Scholar

10. Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau MF, et al. Protective role of interleukin-10 in atherosclerosis. Circ Res. 1999; 85:17-24.10.1161/01.RES.85.8.e17Open DOISearch in Google Scholar

11. Kahraman S, Yilmaz R, Arici M, Altun B, Erdem Y, Yasavul U, et al. IL-10 genotype predicts serum levels of adhesion molecules, inflammation and atherosclerosis in hemodialysis patients. J. Nephrol. 2006; 19:50-6.Search in Google Scholar

12. George S, Ruan XZ, Navarrete C, Turner D, Reynard M, Sweny P. et al. Renovascular disease is associated with low producer genotypes of the anti-inflammatory cytokine interleukin-10. Tissue Antigens. 2004; 63: 470-5.10.1111/j.0001-2815.2004.00183.x15104679Open DOISearch in Google Scholar

13. Martinez-Rios MA, Pena-Duque MA, Fragoso JM, Delgadillo-Rodriguez H, Rodriguez-Perez JM, Miranda-Malpica E, et al. Tumor necrosis factor alpha and interleukin 10 promoter polymorphisms in Mexican patients with restenosis after coronary stenting. Biochem Genet. 2009; 47:707-16.10.1007/s10528-009-9268-919585232Search in Google Scholar

14. Donger C, Georges JL, Nicaud V, Morrison C, Evans A, Kee F, Arveiler D, et al. New polymorphisms in the interleukin-10 gene-relationships to myocardial infarction. Eur J Clin Invest. 2001; 31:9-14.10.1046/j.1365-2362.2001.00754.x11168433Open DOISearch in Google Scholar

15. Koch W, Kastrati A, Böttiger C, Mehilli J, von Beckerath N, Schomig A. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis. 2001; 159:137-44.10.1016/S0021-9150(01)00467-1Open DOISearch in Google Scholar

16. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997; 24:1-8.10.1111/j.1365-2370.1997.tb00001.xOpen DOISearch in Google Scholar

17. Mok CC, Lanchbury JS, Chan DW Lau CS. Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum. 1998; 41:1090-5.10.1002/1529-0131(199806)41:6<1090::AID-ART16>3.0.CO;2-6Open DOISearch in Google Scholar

18. Afzal MS, Anjum S, Salman A, Ashraf S, Farooqi ZR, Ahmed T, et al. Interleukin-10 gene promoter polymorphism as a potential host susceptibility factor in Pakistani patients with pulmonary tuberculosis. Afr J Biotechnol. 2011; 10:14706-10.10.5897/AJB10.2288Open DOISearch in Google Scholar

19. Afzal MS, Tahir S, Salman A, Baig TA, Shafi T, Zaidi NS, et al. Analysis of interleukin-10 gene polymorphisms and hepatitis C susceptibility in Pakistan. J. Infect. Dev. Ctries. 2011; 5:473-9.Search in Google Scholar

20. Hulkkonen J, Pertovaara M, Antonen J, Lahdenpohja N, Pasternack A, Hurme M. Genetic association between interleukin-10 promoter region polymorphisms and primary Sjogren’s syndrome. Arthritis Rheum. 2001; 44:176-9.10.1002/1529-0131(200101)44:1<176::AID-ANR23>3.0.CO;2-KOpen DOISearch in Google Scholar

21. Perrey C, Turner ST, Pravica V, Howell WM, Hutchinson IV. ARMS-PCR methodologies to determine IL- 10, TNF.a, TNF-B and TGF-B1 gene polymorphisms. Transplant Immunology. 1998; 7: 127-8.10.1016/S0966-3274(99)80030-6Search in Google Scholar

22. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999; 340:115-26.10.1056/NEJM199901143400207Search in Google Scholar

23. Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P. Polymorphic haplotypes of the interleukin-10 59 flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum. 1999; 42:1101-8.10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-YOpen DOISearch in Google Scholar

24. Xie G, Myint PK, Zhao L, Li Y, Wang H, Liang L, et al. Relationship between -592A/C polymorphism of interleukin-10 [IL-10] gene and risk of early carotid atherosclerosis. Int J Cardiol. 2010; 143:102-4.10.1016/j.ijcard.2008.11.173Search in Google Scholar

25. Trompet S, Pons D, DE Craen AJ, Slagboom P, Shepherd J, Blauw GJ, et al. Genetic variation in the interleukin-10 gene promoter and risk of coronary and cerebrovascular events: the PROSPER study. Ann N Y Acad Sci. 2007; 1100:189-98.10.1196/annals.1395.018Search in Google Scholar

26. Lio D, Candore G, Crivello A, Scola L, Colonna- Romano G, Cavallone L, et al. Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease. J Med Genet. 2004; 41:790-4.10.1136/jmg.2004.019885Open DOISearch in Google Scholar

27. Hirashiki A, Yamada Y, Murase Y, Suzuki Y, Kataoka H, Morimoto Y, et al. Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors. J Am Coll Cardiol. 2003; 42:1429-37.10.1016/S0735-1097(03)01062-3Open DOISearch in Google Scholar

28. Oda K, Tanaka N, Arai T, Araki J, Song Y, Zhang L, et al. Polymorphisms in pro- and anti inflammatory cytokine genes and susceptibility to atherosclerosis: a pathological study of 1503 consecutive autopsy cases. Hum Mol Genet. 2007; 16:592-9.10.1093/hmg/ddl48317213232Search in Google Scholar

29. Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Boersma E, Simoons ML, et al. Serum level of the anti-inflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation. 2003; 107: 2109-14.10.1161/01.CIR.0000065232.57371.2512668510Open DOISearch in Google Scholar

30. Altun B, Yilmaz R, Kahraman S, Genotoy G, Arici M, Onalan O, et al. Impact of cytokine gene polymorphism on cardiovascular risk in renal transplant recipients. Transpl Int. 2005; 18:681-9.10.1111/j.1432-2277.2005.00118.x15910294Open DOISearch in Google Scholar

31. Ambrosius W, Kazmierski R, Michalak S, Kozubski W. Anti-inflammatory cytokines in subclinical carotid atherosclerosis. Neurology. 2006; 66:1946-8.10.1212/01.wnl.0000219808.28678.4816801669Open DOISearch in Google Scholar

32. Lakoski SG, Liu Y, Brosnihan KB, Herrington DM. Interleukin-10 concentration and coronary heart disease [CHD] event risk in the estrogen replacement and atherosclerosis [ERA] study. Atherosclerosis. 2008; 197:443-7.10.1016/j.atherosclerosis.2007.06.033227917617706223Search in Google Scholar

33. Yamada Y, Izawa H, Ichihara S, Takatsu F, Ishihara H, Hirayama H, et al. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl JMed. 2002; 347:1916-23.10.1056/NEJMoa02144512477941Search in Google Scholar

34. Blanco E, Monux G, Mas A, Serrano FJ, de la Concha EG, Urcelay E. Role of IL-10 promoter polymorphisms in tmhe development of severe aorto-iliac occlusive disease. Hum Immunol. 2008; 69:651-4.10.1016/j.humimm.2008.07.00518703105Open DOISearch in Google Scholar

35. Koch W, Tiroch K, Beckerath NV, mig AS, Kastrati A. Tumor necrosis factor-a, lymphotoxin-a, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting. Cytokine. 2003; 24:161-71.10.1016/j.cyto.2003.08.00414572794Open DOISearch in Google Scholar

36. Densem CG, Hutchinson IV, Yonan N, Brooks NH. Influence of interleukin-10 polymorphism on the development of coronary vasculopathy following cardiac transplantation. Transplant Immunology. 2003; 11:223-8.10.1016/S0966-3274(03)00015-7Open DOISearch in Google Scholar

37. Mälarstig A, Eriksson P, Hamsten A, Lindahl B, Wallentin L, Siegbahn A. Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome. Heart. 2008; 94:724-9.10.1136/hrt.2007.119271Open DOISearch in Google Scholar

38. Anguera I, Miranda-Guardiola F, Bosch X, Filella X, Sitges M, Mar_n JL, et al. Elevation of serum levels of the anti-inflammatory cytokine interleukin-10 and decreased risk of coronary events in patients with unstable angina. Am Heart J. 2002; 144:811-7.10.1067/mhj.2002.124831Open DOISearch in Google Scholar

39. Tziakas DN, Chalikias GK, Hatzinikolaou HI, Parissis JT, Papadopoulos ED, Trypsianis GA, et al. Antiinflammatory cytokine profile in acute coronary syndromes: behavior of interleukin-10 in association with serum metalloproteinases and proinflammatory cytokines. Int J Cardiol. 2003; 92:169-75. 10.1016/S0167-5273(03)00084-6Open DOISearch in Google Scholar